| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.005 |